Antibiotic-Specific Risk for Community-Acquired <i>Clostridioides difficile</i> Infection in the United States from 2008 to 2020-Reference-Cited by-同舟云学术

Antibiotic-Specific Risk for Community-Acquired Clostridioides difficile Infection in the United States from 2008 to 2020

Published:2022-12-20 Issue:12 Volume:66 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Zhang Jimmy¹^ORCID,Chen Ling²,Gomez-Simmonds Angela³^ORCID,Yin Michael T.³,Freedberg Daniel E.¹^ORCID

Affiliation:

1. Division of Digestive and Liver Diseases, Columbia University Irving Medical Center–New York Presbyterian Hospital, New York, New York, USA

2. Department of Obstetrics and Gynecology, Columbia University Irving Medical Center–New York Presbyterian Hospital, New York, New York, USA

3. Division of Infectious Diseases, Columbia University Irving Medical Center–New York Presbyterian Hospital, New York, New York, USA

Abstract

Antibiotic exposure is a crucial risk factor for community-acquired Clostridioides difficile infection (CA-CDI). However, the relative risks associated with specific antibiotics may vary over time, and the absolute risks have not been clearly established.

Funder

U.S. Department of Defense

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.01129-22

Reference37 articles.

1. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

2. Current Trends in the Epidemiology and Outcomes of Clostridium difficile Infection

3. Burden of Clostridium difficile on the Healthcare System